Navigation Links
Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes
Date:9/11/2008

d paper was presented at the Symposium highlighting the use of Synvista's proprietary diagnostic kit for quantifying carboxymethyl-lysine (CML), a dominant advanced glycation end product (A.G.E.). The study demonstrated that CML is a biomarker of mortality in the elderly.

About Haptoglobin

The best understood function of haptoglobin (Hp), a common serum protein, is to bind free hemoglobin released from red blood cells. Extracellular hemoglobin (hemoglobin not found in red blood cells) is a potent oxidizing agent capable of inflicting oxidative tissue damage. Haptoglobin binds to this extracellular hemoglobin and inhibits hemoglobin induced oxidation. Once hemoglobin is bound to haptoglobin, it is rapidly cleared from the bloodstream by the liver or specialized white blood cells.

Haptoglobin in humans exists as three different proteins that arise from one of three haptoglobin gene combinations in the population, Hp 1-1 (16%), Hp2-2 (36%) and Hp1-2 (48%) For a variety of reasons, well described in the literature, Hp2-2 is more effective than Hp1-1 at preventing hemoglobin-induced oxidation in the bloodstream and blood vessel wall.

As a result, scientists have determined that the rate of heart disease is five times higher in Hp2-2 Diabetes than in Hp1-1 Diabetes. Hp2-2 Diabetes also has higher rates of myocardial infarction and re-vascularization within one year of angioplasty, and of heart failure and death following a heart attack. Prospective clinical trials have demonstrated that the rate of heart attack in Hp2-2 Diabetes can be decreased by the administration of natural Vitamin E (400IU). This combination of testing and treatment exemplifies pharmacogenomics, the targeting of a particular drug on the basis of genetic testing.

About Synvista Therapeutics

Synvista Therapeutics is a biopharmaceutical company developing diagnostics and drugs to diagnose, treat and prevent cardiovascular disease in people with diabetes. The Com
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
2. Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A
3. Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naive HIV-Infected Patients
4. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
5. New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients
6. New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes
7. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
8. Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer
9. Data Confirm Avastin(R) Helps Patients With Metastatic Colorectal Cancer Live Even Longer
10. AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients
11. New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com announces ... in its catalogue: Global Coatings for ... This report analyzes the ... US$ Million by the following Product Segments: Active ... The report provides separate comprehensive analytics for the ...
(Date:8/20/2014)... , Aug. 20, 2014 ApolloDx™ today announced ... platform during a special event at the company,s office ... on September 5, 2014. The event, which will start ... ApolloDx website, www.apollodx.com .    "We ... said Jared Bauer , Co-Founder and Managing Partner ...
(Date:8/20/2014)... 20, 2014   Easy Breathe , the fastest growing online ... Easy Blog " - has received more than 4.5 million unique ... "We are thrilled that so many people are finding our blog ... Easy Breathe. "We,re committed to making sleep apnea more widely known ... informed about sleep apnea news , troubleshooting advice , ...
Breaking Medicine Technology:Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4
... U.S. Food and Drug Administration recently approved the NovoTTF-100A ... multiforme (GBM) that recurs or progresses after receiving chemotherapy ... Brain tumors are the growth of ... National Cancer Institute, each year about 19,000 people in ...
... announced that the U.S. Food and Drug Administration ... treatment of adult patients with glioblastoma multiforme (GBM) ...  The portable, wearable device delivers an anti-mitotic, anti-cancer ... The NovoTTF is a novel, first-in-class treatment option ...
Cached Medicine Technology:FDA Approves New Medical Device for Form of Brain Cancer 2FDA Approves New Medical Device for Form of Brain Cancer 3FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors 2FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors 3FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors 4
(Date:8/21/2014)... 2014 Teen substance abuse is long been ... The rising numbers of young adults falling victim to a ... a difference in the community, the new Troubled Teens Boca ... teens seeking to overcome something like teenage alcohol abuse ... teens find the best teen recovery facility to focus on ...
(Date:8/21/2014)... Drake University’s Phi Gamma Delta (FIJI) ... ovarian cancer research, according to Billy Cundiff, President of ... kicker for the Cleveland Browns, says the money raised ... Colleen’s Dream Foundation and will fund research to be ... the Division of Gynecologic Oncology at the University of ...
(Date:8/21/2014)... 21, 2014 Today, Fecbek.com, a leading ... new designs of wedding dresses. And all these elegant, ... designed by excellent designers. , A wedding dress or ... during a wedding ceremony. Color, style and ceremonial importance ... culture of the wedding participants. In order to satisfy ...
(Date:8/20/2014)... Skmen.com, the popular online supplier of men’s and women’s clothes, ... online. Along with this, the company has also launched ... fresh products are offered with great discounts and low shipping ... before August 31. , Skmen.com has more than 200 ... proportion of its clothes are selling well in the current ...
(Date:8/20/2014)... PAINWeek, the National Conference on ... Nadelmann, JD, PhD, will deliver the Keynote Address ... and executive director of the Drug Policy Alliance, ... alternatives to the war on drugs. As a ... and internationally, he has played a pivotal role ...
Breaking Medicine News(10 mins):Health News:New Helpline Provides Hope for Troubled Teens in Boca Raton 2Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 2Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 3Health News:Elegant Wedding Dresses Are for Sale at Fecbek.com 2Health News:Skmen.com: New Designs Of Mini Party Dresses Provided Online 2Health News:PAINWeek Welcomes Ethan Nadelmann, JD, PhD, as Keynote Speaker at 2014 Conference 2
... By Serena Gordon HealthDay Reporter , THURSDAY, ... four new studies suggest that you could benefit from longer ... done at home or at a dialysis center, but it ... rates and improve quality of life, according to the research ...
... Voluminous research literature attests to the multiple negative ... health and development of children. In contrast, there is ... fathers according to a follow up study by NYU ... edition of Maternal and Child Health Journal. ...
... Doheny HealthDay Reporter , THURSDAY, Feb. 23 (HealthDay ... reduce stroke risk, new research suggests. Diets rich in ... in other studies, but researchers weren,t sure why. For this ... citrus fruits and found a winner. "These data provide ...
... Dotinga HealthDay Reporter , THURSDAY, Feb. 23 (HealthDay ... of those known to be infected, actually struck many more ... analysis finds. The actual fatality rate of the H5N1 ... that millions of people may have been infected over the ...
... B, AB or O. You may even know if you,re ... type? Or the Junior blood type? Positive or negative? Most ... knowledge could be "a matter of life and death," says ... problems due to Langereis and Junior blood types are rare ...
... , THURSDAY, Feb. 23 (HealthDay News) -- ... and emergency department visits, improved patient outcomes and saved ... study. Researchers examined the impact of the Community ... families, developed and implemented in 2005 by a team ...
Cached Medicine News:Health News:More Kidney Dialysis Is Better, Research Finds 2Health News:More Kidney Dialysis Is Better, Research Finds 3Health News:Characteristics of fathers with depressive symptoms 2Health News:Characteristics of fathers with depressive symptoms 3Health News:Citrus Fruits May Lower Women's Stroke Risk 2Health News:Citrus Fruits May Lower Women's Stroke Risk 3Health News:'Bird' Flu May Be More Common in Humans, But Less Deadly 2Health News:Blood mystery solved 2Health News:Blood mystery solved 3Health News:Home-Visit Program May Improve Child's Asthma 2
Pain management can be complicated. But that doesn't mean your PCA infusion system should be. The new SYNDEO PCA Syringe Pump streamlines pain therapy with a powerful combination of intelligent desig...
... be customized with selectable performance parameters for ... therapies. The COLLEAGUE pumps allow the ... for both gravity and pump regulation, eliminating ... infusions to medication therapies requiring complex dose ...
... 1979, CRL offers leading-edge ... the areas of Toxicology, ... Trials and Genomics ... at our 150,000 square ...
Millenova Immunology Laboratories is a reference laboratory dedicated to the diagnosis of immunologic causes of reproductive failure, infertility and recurrent pregnancy loss....
Medicine Products: